D-Pharma SRL
The score of D-Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity +17 % Total assets +22 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
D-Pharma's annual accounts
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Net result | 34,289 € | ||||
| Equity | 284,914 € | ||||
| Cash | 35,515 € | ||||
| EBITDA | 42,014 € | ||||
| Total assets | 427,889 € |
Filed annual accounts
- Year ended 31 Mar 2024filed on 28 Nov 2024
- Year ended 31 Mar 2023filed on 30 Nov 2023
- Year ended 31 Mar 2022filed on 30 Dec 2022
- Year ended 31 Mar 2021filed on 29 Nov 2021
- Year ended 31 Mar 2020filed on 13 Nov 2020
D-Pharma's financial analysis
- Solvency66.6%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of D-Pharma
D-Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0455.755.092
- VAT number
- BE0455755092
- Peppol
- Registered · 0208:0455755092 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 Jul 1995
- Registered office
- 1030 Schaerbeek
- Latest accounts
- 2024 · filed on 28 Nov 2024
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
D-Pharma (SRL) has been based in Schaerbeek since 1995, active in: retail sale of pharmaceutical products. For 2024, it reports a net profit of 34,289 € and equity of 284,914 €; its revenue is not published. Its solvency stands at 66.6%, above the median of its sector (37.8%).
Companies similar to D-Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DU Diamant Retail sale of pharmaceutical products Schaerbeek · balance sheet 428,901 €
- Maxpharma Retail sale of pharmaceutical products Etterbeek · balance sheet 426,986 €
- Apotheke Bocken Retail sale of pharmaceutical products Eupen · balance sheet 426,403 €
- Maria Brughmans Apotheker Retail sale of pharmaceutical products Baarle-Hertog · balance sheet 429,618 €
- Apotheek Deckers Retail sale of pharmaceutical products Antwerp · balance sheet 429,684 €
- Coriphar Retail sale of pharmaceutical products Tienen · balance sheet 425,689 €
- Essential Pharma Retail sale of pharmaceutical products Seraing · balance sheet 430,671 €
- Apoteek Kestens Retail sale of pharmaceutical products Duffel · balance sheet 431,698 €
Frequently asked questions about D-Pharma
What is the revenue of D-Pharma?
D-Pharma files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of D-Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0455755092 for D-Pharma, if the company is VAT-registered. Its company number (CBE) is 0455.755.092.
Where is the registered office of D-Pharma?
According to the CBE register, the registered office of D-Pharma is in 1030 Schaerbeek.
What is the equity of D-Pharma?
At the close of the 2024 financial year, the equity of D-Pharma amounts to 284,914 €, a solvency of 66.6% of total assets.
Who manages D-Pharma?
The register lists 1 active mandates at D-Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of D-Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →